's Chart of the Day - Blueprint Medicines

The Chart of the Day belongs to Blueprint Medicines (BPMC).  I found the oncology stock by using Barchart to sort today's All Time High list first by the highest Weighted Alpha then for technical buy signals of 80% or more.  Since the Trend Spotter signaled a buy on 2/27 the stock gained 25.96%.

Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA.

The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the web site when you read this report.

Barchart technical indicators:

  • 96% technical buy signals

  • Trend Spotter buy signal

  • Above its 20, 50 and 100 day moving averages

  • 8 new highs and up 11.08% in the last month

  • Relative Strength Index 63.60%

  • Technical support level at 45.48

  • Recently traded at 46.00 with a 50 day moving average of 25.96

Fundamental factors:

  • Market Cap $1.79 billion

  • Revenue expected to shrink in the short term

  • Earnings estimated to be at a loss in the short term

  • This is a stock that is expected to be developing a good pipeline of products in the future

  • Despite the lack of short term returns Wall Street analysts issued 4 strong buy and 2 buy recommendation for the stock

View more information for today's symbol:

Quotes and Charts
Detailed Quote

Technical Analysis
Technicals Summary
Trader's Cheat Sheet

Barchart Opinions
Barchart Opinion
Barchart Snapshot
Trading Strategies

Company Info
Company Profile
Key Statistics
Income Statement-Quarterly
Income Statement-Annual
Balance Sheet-Current
Balance Sheet-Annual

Chart of the Day Archive
View Past Chart of the Day Reports

Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks